Kain Capital

Sameer Mathur is a Partner at Kain Capital, where he focuses on sourcing, executing, and managing healthcare companies in the portfolio. He has more than 16 years of principal investing experience and previously worked at Bain and Company, Francisco Partners, DW Healthcare Partners, and Chicago Pacific Founders. He holds a Bachelor of Science in Biomedical Engineering and Economics from Northwestern University.

Steven Yecies is founder and managing partner of New Dimensions Health Fund. He has experience as an investor, entrepreneur, and operating manager across healthcare IT, healthcare services, consumer health, life sciences, and enterprise software. His background includes venture investing, acquisitions and divestitures, and building management teams in healthcare and technology businesses.

Telly Hoimes is a Partner at Kain Capital, which he joined in 2015. He previously co-founded Harris & Hoimes, Inc., a middle market private equity firm, and was a co-founding general partner of TSG Consumer Partners, which manages more than $5B of investor capital. He holds an MBA from New York University and a B.S. from Cornell University.

Jimmy Qiu is a Principal at Kain Capital with about a decade of investment experience. He was previously a Principal at Emerging Sovereign Group, a hedge fund once part of the Carlyle Group, and earlier invested in healthcare at Apax Partners after beginning his career in the Mergers & Acquisitions Group at Credit Suisse. He holds an A.B. in Economics from The University of Chicago.

Long Thai is an executive at Rendr, an NYC-based physician group serving the Asian community, where he leads the shift to value-based care using financial and operational analytics for risk coding and utilization management. He has more than 20 years of experience with integrated multi-specialty medical groups, including ChenMed and Kaiser Permanente, where he helped the Mid-Atlantic Region grow from 485,000 to 775,000 members. He holds a BA in Biology from Wesleyan University and an MBA from the Haas School of Business at the University of California, Berkeley.

Ben Sagalyn is a Vice President on the investment team at Kain Capital. He was previously a Senior Associate at Pinta Capital Partners, a healthcare-focused family office where he worked on private company investments, and earlier held roles at Endeavour Capital, a generalist private equity firm, and in Bank of America's Healthcare Group. He holds a bachelor's degree from Indiana University.

Bret Cummings has over 30 years of experience in investment management, including 25 years at alternative investment firms. He has held Chief Financial, Operating, and Compliance roles at New York-based hedge funds including Macellum Capital Management, Healy Circle Capital Management, Sage Asset Management, and Irvine Capital Management. He holds a BS in Finance from Fairfield University and has been a Chartered Financial Analyst since 1999.

Bridie Gahan is Vice President of Strategy at Kain Capital, with experience across investing and operating in healthcare. She began her career on the Privates team at Coatue Management, later helped launch and manage Cantos Ventures, and led healthcare investing at Lifeforce Capital while at Columbia Business School. Her operating roles include leadership positions at Faeth Therapeutics in oncology care and Astrana Health in value-based care. She holds a BSc in Science and Technology Studies from Brown University and an MBA from Columbia University.

Chenghao Guo is Associate Director of Data Analytics at Kain Capital. His skills include SQL, Python, Qlik View/Sense, Power BI, ETL, data modeling, change management, vendor management, and business process improvement. He also has a background in luxury lifestyle hotel management, with experience in P&L, CAPEX, and revenue strategies.

Dennis Nesta is an Operating Partner at Kain Capital with nearly two decades of healthcare experience across health plans and providers, focused on transforming organizations toward value-based care. He first connected with Kain Capital as CFO of Excelsior, a portfolio company, and after helping lead its merger with Rendr became Chief Strategy Officer of Rendr, where he oversaw the shift from fee-for-service to managing about $1bn in risk premium. He previously held market and corporate leadership roles at Aetna, Cigna, and served as a Regional CFO at ChenMed.

Domenic DiPasquale is the Operations Associate at Kain Capital, where he supports and improves business processes using technology. He works as a tech and business analyst and has experience helping startups navigate operations leadership transitions. He holds a B.S. in Business Administration and Mechanical Engineering from Carnegie Mellon University.

Frank Jerez is a technology and software development leader with over 15 years of experience building data-driven platforms for healthcare organizations. He is a technology leader at Lance Health, contributing to the engineering behind an AI-powered clinical documentation platform for home health agencies. Earlier, at ChenMed, he built an enterprise analytics platform that used AI to detect missing diagnoses across large volumes of medical records and patients.

Harry Zirinsky is Head of Business Development & Strategy at Kain Capital. He previously worked as a portfolio manager at Bienville Capital Management and Talpion Fund Management, managing a cross-asset absolute return portfolio across products and geographies with a focus on risk management. He started his career at BNP Paribas trading interest rate swaps and derivatives, and holds a Bachelor of Business Administration from Emory University.

Pedro Licea is a Senior Software Engineer with 16 years in the software industry, focused on healthcare technology, data automation, and clinical workflow optimization. At ChenMed, he has worked for three years on scalable systems for clinical data processing, documentation intelligence, claims analysis, and workflow automation.

Phillip Franz is an Operating Partner at Kain Capital with over 30 years of experience in health insurance and managed care across Commercial, Medicare, and Medicaid lines. He previously held payer-side finance leadership roles including Market CFO, Regional CFO, and VP of Finance, and served as Health Plan CEO for Medicare Advantage NY & NJ at United Healthcare. His work has focused on healthcare finance, Medicare Advantage operations, health plan turnarounds, and transitions into value-based contracts.

Xi Zheng is a Data Scientist at Kain Capital. She previously applied machine learning and data science methods to analyze cost and medical economics at Chenmed, and interned at KPMG building machine learning models for tax optimization for airlines and banks, as well as at Anheuser-Busch in data analysis. She holds a B.S. in Statistics from the University of Minnesota and an M.S. in Data Science from the University of Michigan.

Executive Assistant to the Chairman handling day-to-day operational logistics in the Chairman's office. She previously ran the executive office and special events for the American Enterprise Institute with nearly a decade of executive office and event management experience.

Managing Director of Investment Management leading the Investment Management team and a member of the Executive and Investment Committees. He has over two decades of experience building investment organizations across healthcare, higher education, corporate, and family office settings.

Ian Hunt is an Analyst on the Investor Relations and Communications team at Closed Loop Partners. His work focuses on areas including the circular economy, climate education, and energy justice.

Director of Capital Formation responsible for sourcing and evaluating investment themes and facilitating outside investor co-investment. He has more than a decade of alternative investment experience, beginning at Morgan Stanley Investment Management and most recently at Abbey Capital.

Partner who leads portfolio management and investment diligence and sits on the Executive and Investment Committees. He joined CAZ in 2014 with over 20 years of investment experience in derivatives, commodities, hedge funds and private markets, and holds the CAIA designation.